Paul A Mahon United Therapeutics Corp (UTHR) insider trading activity

UTHR Quotes by TradingView

Paul A Mahon is EVP & GENERAL COUNSEL of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 36,710 shares of UTHR, which is worth approximately $15.1 Million. The most recent transaction as insider was on Nov 07, 2024, when has been sold 7,700 shares (Common Stock) at a price of $402.57 per share, resulting in proceeds of $3,099,789. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.7K
0% 3M change
0.3% 12M change
Total Value Held $15.1 Million

PAUL A MAHON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 07 2024
SELL
Sale (or disposition) back to the issuer
$3,099,789 $402.57 p/Share
7,700 Reduced 17.34%
36,710 Common Stock
Nov 07 2024
BUY
Exercise of conversion of derivative security
$1,257,410 $163.3 p/Share
7,700 Added 14.78%
44,410 Common Stock
Oct 17 2024
SELL
Sale (or disposition) back to the issuer
$2,870,637 $372.81 p/Share
7,700 Reduced 17.34%
36,710 Common Stock
Oct 17 2024
BUY
Exercise of conversion of derivative security
$1,257,410 $163.3 p/Share
7,700 Added 14.78%
44,410 Common Stock
Oct 03 2024
SELL
Sale (or disposition) back to the issuer
$2,695,539 $350.07 p/Share
7,700 Reduced 17.34%
36,710 Common Stock
Oct 03 2024
BUY
Exercise of conversion of derivative security
$1,257,410 $163.3 p/Share
7,700 Added 14.78%
44,410 Common Stock
Sep 19 2024
SELL
Sale (or disposition) back to the issuer
$2,705,241 $351.33 p/Share
7,700 Reduced 17.34%
36,710 Common Stock
Sep 19 2024
BUY
Exercise of conversion of derivative security
$1,257,410 $163.3 p/Share
7,700 Added 14.78%
44,410 Common Stock
Jun 20 2024
SELL
Sale (or disposition) back to the issuer
$7,724,500 $308.98 p/Share
25,000 Reduced 40.51%
36,710 Common Stock
Jun 20 2024
BUY
Exercise of conversion of derivative security
$4,082,500 $163.3 p/Share
25,000 Added 28.83%
61,710 Common Stock
Apr 04 2024
SELL
Open market or private sale
$1,392,120 $232.02 p/Share
6,000 Reduced 14.05%
36,710 Common Stock
Apr 04 2024
BUY
Exercise of conversion of derivative security
$706,560 $117.76 p/Share
6,000 Added 12.32%
42,710 Common Stock
Mar 21 2024
SELL
Open market or private sale
$1,415,880 $235.98 p/Share
6,000 Reduced 14.05%
36,710 Common Stock
Mar 21 2024
BUY
Exercise of conversion of derivative security
$706,560 $117.76 p/Share
6,000 Added 12.32%
42,710 Common Stock
Mar 07 2024
SELL
Open market or private sale
$1,427,040 $237.84 p/Share
6,000 Reduced 14.08%
36,599 Common Stock
Mar 07 2024
BUY
Exercise of conversion of derivative security
$706,560 $117.76 p/Share
6,000 Added 12.35%
42,599 Common Stock
Feb 15 2024
SELL
Open market or private sale
$1,292,040 $215.34 p/Share
6,000 Reduced 14.08%
36,599 Common Stock
Feb 15 2024
BUY
Exercise of conversion of derivative security
$706,560 $117.76 p/Share
6,000 Added 12.35%
42,599 Common Stock
Feb 01 2024
SELL
Open market or private sale
$1,290,300 $215.05 p/Share
6,000 Reduced 14.08%
36,599 Common Stock
Feb 01 2024
BUY
Exercise of conversion of derivative security
$706,560 $117.76 p/Share
6,000 Added 12.35%
42,599 Common Stock
Jan 18 2024
SELL
Open market or private sale
$1,318,680 $219.78 p/Share
6,000 Reduced 14.08%
36,599 Common Stock
Jan 18 2024
BUY
Exercise of conversion of derivative security
$706,560 $117.76 p/Share
6,000 Added 12.35%
42,599 Common Stock
Jan 04 2024
SELL
Open market or private sale
$1,368,660 $228.11 p/Share
6,000 Reduced 14.08%
36,599 Common Stock
Jan 04 2024
BUY
Exercise of conversion of derivative security
$706,560 $117.76 p/Share
6,000 Added 12.35%
42,599 Common Stock
Dec 21 2023
SELL
Open market or private sale
$1,361,940 $226.99 p/Share
6,000 Reduced 14.08%
36,599 Common Stock
PAM

Paul A Mahon

EVP & GENERAL COUNSEL
Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on UTHR